Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
CBD CliniLabs LLC
*STREET
7000 Broadway, Suite 307
*CITY
Denver
*STATE
(Required for U.S. applicants)
Colorado
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
80221
LEGAL ENTITY INFORMATION
TYPE
limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED
Colorado
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
042
*IDENTIFICATION
Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Clinton J. Cusick
ATTORNEY DOCKET NUMBER
2324-102.42
FIRM NAME
Cusick IP, PLLC
STREET
716 N. Bethlehem Pike, Suite 302
CITY
Ambler
STATE
Pennsylvania
COUNTRY
United States
ZIP/POSTAL CODE
19002-2656
CORRESPONDENCE INFORMATION
NAME
Clinton J. Cusick
FIRM NAME
Cusick IP, PLLC
STREET
716 N. Bethlehem Pike, Suite 302
CITY
Ambler
STATE
Pennsylvania
COUNTRY
United States
ZIP/POSTAL CODE
19002
PHONE
215-853-8255
FAX
2156474884
*EMAIL ADDRESS
ccusick@cusickip.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
275
*TOTAL FEE PAID
275
SIGNATURE INFORMATION
SIGNATURE
/Sean Callan/
SIGNATORY'S NAME
Sean Callan
SIGNATORY'S POSITION
Senior Vice President
DATE SIGNED
02/11/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88297625
Filing Date:02/12/2019
To the Commissioner for Trademarks:
MARK: ISOQ (Standard Characters, see mark)
The literal element of the mark consists of ISOQ.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, CBD CliniLabs LLC, a limited liability company legally organized under the laws of Colorado, having an address of
7000 Broadway, Suite 307
Denver, Colorado 80221
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Clinton J. Cusick of Cusick IP, PLLC 716 N. Bethlehem Pike, Suite 302
Ambler, Pennsylvania 19002-2656
United States
The attorney docket/reference number is 2324-102.42.
The applicant's current Correspondence Information:
Clinton J. Cusick
Cusick IP, PLLC
716 N. Bethlehem Pike, Suite 302
Ambler, Pennsylvania 19002
215-853-8255(phone)
2156474884(fax)
ccusick@cusickip.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Sean Callan/ Date: 02/11/2019
Signatory's Name: Sean Callan
Signatory's Position: Senior Vice President
Payment Sale Number: 88297625
Payment Accounting Date: 02/12/2019
Serial Number: 88297625
Internet Transmission Date: Tue Feb 12 10:32:17 EST 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2019021210321705
2191-88297625-620952e34ecd6749c1c6c1afbe
ea4160a6bd187c691ac7e68c2a7ddb937dc434a-
CC-8926-20190211180746826841